Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Long-term Remission in Juvenile Myoclonic Epilepsy
S44 - Epilepsy/Clinical Neurophysiology (EEG): Epilepsy Outcomes
One third of people  with Juvenile myoclonic epilepsy (JME) do not respond to anti-seizure medications (ASMs) and in the remaining, seizure relapses are not uncommon when attempting to withdraw the ASMs. 
To analyze the long-term remission in people with Juvenile Myoclonic epilepsy (JME) and determine the predictors of long-term remission.

This is a retrospective observational study of persons with JME with a follow-up of 5 to 20 years. The clinical details, inter-ictal EEG and ASM response details were recorded.

 A total of 231 patients were included; 64% of the patients had an age of onset of 11-18 years (mean age 14.6 years). 38% had positive family history. Nearly 52% patients had a delay in the diagnosis of JME by > 1year. Among the seizure types, GTCS was noted in 96.1% patients while absence seizures were reported in 24.5%.  Nearly 22% patients had all types of seizures. 36% had praxis induced seizures. Photo Paroxysmal Response (PPR) was noted on the EEG in 47% patients; Focal EEG abnormalities were noted in 29% patients. Motor seizures during sleep was reported in in 41.5% patients.  The longest freedom of any seizure type for more than 10 years was achieved in 11%, more than 5 years achieved in 40% yet recurrence of any   seizure after withdrawal was noticed in 70% of patients. Presence of all three seizure types, praxis induced seizures, positive PPR and focal EEG abnormalities were the predictors of poor remission.  

Long term follow-up showed despite long periods of seizure freedom recurrence rates following anti-seizure medication withdrawal were high.  Presence of all three seizure types, praxis induced seizures, positive PPR and focal EEG abnormalities were the predictors of poor remission in people with JME.  

Authors/Disclosures
Shashank Jaiswal
PRESENTER
Mr. Jaiswal has nothing to disclose.
Sita Jayalakshmi Sattaluri (Krishna Institute of Medical Sciences) Dr. Sattaluri has nothing to disclose.
Anuja R. Patil, MD, DM (26, Dept of Neurology, 3rd floor ) Dr. Patil has nothing to disclose.